Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-24 @ 9:28 PM
NCT ID:
NCT03946332
Eligibility Criteria:
Inclusion Criteria:
* Under 65-year-old patient
* more than 18 years old
* Hospitalized for autologous stem cell transplantation
* First or second line therapy for multiple myeloma
* Chemotherapy regimen with melphalan
* Patient affiliated to the social security system
* Signed informed consent form
* Patient who have computer and internet connection at home
Exclusion Criteria:
* Over-65-year-old patient
* Other haematological malignancies
* More than 2 treatment lines
* Other regimen of chemotherapy for autograft than melphalan
* Contraindication to physical exercises: uncontrolled arterial hypertension or diabetes, heart or respiratory failure, psycho-cognitive disorders that may compromise the physical exercises program
* dialyzed patient
* Adult patient under tutelage
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03946332
Study Brief:
Protocol Section:
NCT03946332